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Frequency of Hepatitis B, Hepatitis C and Human Immunodeficiency
virus in patients undergoing cataract surgery
Mahfouth Abdalla Bamashmus*

Ahmed Mousa Abdulrahim**
Abstract

The aim of this study is to assess the frequency of Hepatitis B (HBV), Hepatitis C (HCV) and Human
Immunodeficiency (HIV) viral infections in patients undergoing cataract surgery. This study was conducted among
1,203 patients above the age of 17 years who were scheduled for cataract surgery at Yemen Magrabi Hospital from
January 1st, through December 31st, 2012. Patients had investigations for HBV, HCV and HIV and findings were
analyzed. The total number of patients screened was 1,203 including 603 (51.1%) males and 600 (49.9%) females.
The mean (+SD) age was 59.96 + 12.39 years. Out of the 1,203 cataract patients booked for surgery, 130 (10.8%)
turned out to be positive for HBV, HCV and HIV. The total prevalence of HBV and HCV was found to be 81/1203
(6.7%) and 49/1203 (4.1%) respectively. Only one patient was found with a co-infection with both HBV and HCV.
While only one patient (0.83%) was HIV positive. We conclude that the high prevalence of 10.8% of HBV and HCV
among cataract surgery patients suggests that pre-operative viral screening for all patients should be mandatory
prerequisite for conducting the surgery. A solid policy outlining preventive practices are badly needed to control this
phenomenon and prevent its adverse consequences.
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Introduction:
In Yemen, the frequency of Hepatitis B virus
(HBV) ranges from 8 – 12% while hepatitis C
virus (HCV) infection ranges from 1.7 – 2.7% in
the general population with variations in
different parts of the country ]6, 11[. There is a
considerable probability that patients undergoing
any surgical procedure may have such infections
which may require special precautions. Health
workers are at a relatively high risk of
developing these viruses where a study in Yemen
showed that 9.9% of health workers tested were
positive for hepatitis B surface antigen (HBsAg)
and 3.5% had hepatitis C antibodies (antiHCV) ]3, 19[.
The increased prevalence of HBV, HCV and
HIV are of global interest where it is considered
as a major public health problem especially in
developing countries such as Yemen. Moreover,
both HBV and HCV are among the leading
causes of morbidity and mortality worldwide.
Around 80% of affected patients reside in
Asia ]14[ and 50 million new cases of HBV are
commonly diagnosed annually ]16[. Infection
with HBV is endemic worldwide and is
responsible for an estimated 1-2 million global
annual deaths ]14[.
Moreover, the World Health Organization
(WHO) estimates show that around 170 million
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people (3% of the world population) are infected
with hepatitis C virus (HCV) ]20[ whereas, 130
million of whom (76.5%) are chronic HCV
carriers and are at high risk of developing liver
cirrhosis, portal hypertension, ascites, bleeding
esophageal varices and liver cancer. ]20[ The
prevalence of HCV is commonly lower than that
of HBV. However, this fact is quite regionspecific. For example, in Pakistan and Egypt, the
prevalence of HCV is much higher than that of
HBV.]7, 8 [. The common risk factors for
encountering HBV and HCV may include; old
age, being female, certain occupations and bad
hygiene ]5, 9[.
Epidemiologically, both HBV and HIV can be
contracted through the blood, semen, vaginal
fluids, and other body fluids of an infected
individual having either hepatitis B or HIV
infections. However, HCV can only be
contracted through blood to blood contact ]1[.
Since HBV, HCV and HIV viruses are all blood
borne, they are commonly transmitted by
transfusion, use of infected needles, surgical and
dental instruments, and barber shaving
equipment ]10 [. Objects contaminated with
blood and other body fluids of patients suffering
from HBV, HCV and HIV constitute an
occupational health hazard to other exposed
health care personnel. Medical doctors,
particularly surgeons and paramedical staff are at
high occupational risk of encountering these
infections through needle injury or direct transfer
of the virus through cutting skin ]17[.
The aim of the current study is to estimate the
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prevalence of Hepatitis B, Hepatitis C and HIV
among cataract patients booked for surgery in
Sana'a, Yemen.
Patients and method:
The current study follows an observational
descriptive study design based on laboratory
finding of all patients admitted for cataract
surgery at Yemen Magrabi Eye Hospital in
Sana’a from January 1st, and during
December31st, 2012. All cataract patients listed
for surgery were screened for Hepatitis B (HBV),
Hepatitis
C
(HCV)
and
Human
Immunodeficiency Virus (HIV) infections to
investigate whether they were carriers of any of
the mentioned viruses. This study aimed to
determine the frequency of hepatitis B surface
antigen (HBsAg), antibody to hepatitis C virus
(Anti HCV) and antibody to HIV virus (anti
HIV) positive patients among those undergoing
elective cataract surgery. The study was
approved by the Research and Ethics committee
of Yemen Magrabi Eye Hospital, and the
procedures followed were in accordance with the
ethical standards of the responsible committee on
human
experimentation
(institutional
or
regional), and with the Helsinki Declaration of
1975, as revised in 2000.
All admitted patients in the age interval 18 years
and above who underwent cataract surgery were
included in the current study. None of the
patients was eventually excluded from the study.
Demographic and clinical indices were recorded
and stored in a Microsoft Excel 2007 sheet. After
data management, data was later analyzed using
SPSS version 20. Descriptive analysis was done,
where categorical variables were presented as
frequencies and percentages while continuous
variables as mean (±SD). Chi-square test was
used to detect risk factors for glaucoma and the
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need for surgery (Fisher Exact test whenever
indicated). Confidence interval level was set to
95% where a corresponding p value threshold
was identified as 0.05 where any output p below
0.05 would be interpreted as an indicator of
statistical significance.
Rapid chromatography immunoassay for
qualitative detection of surface antigen of
hepatitis B and antibodies for hepatitis C was the
screening technique of choice in this study.
Positive results in the screening test were
confirmed
through
Enzyme-Linked
Immunosorbent Assay (ELISA) method. The
Advanced HBsAG test kitebis which is a onestep enzyme immunoassay was used in the
qualitative detection of Hepatitis B surface
Antigen (HBsAg) in human serum or plasma.
The RecomiLISA HCV IgG Test is a solid phase
enzyme and linked immunoassay was
specifically used to detect IgG of HCV in human
serum or plasma.
RecombiLASA HIV 1 and 2 Antibody tests are a
solid phase enzyme linked and immunoabsorbent
assay was used in the qualitative detection of
anti-HIV-1 and anti-HIV-2 antibodies in human
serum or plasma. Positive patients for HBV,
HCV and HIV were referred for further medical
evaluation and patients’ information was kept
confidential.
Results:
During the study period, a total of 1203 patients
were screened including 603 (51.1%) male and
600 (49.9%) female patients that were included
in the current study. The mean (+SD) age of the
studied population was 59.96 (+ 12.39) years,
where age was further categorized into four age
groups of [18–30], [31–50], [51–70] and [above
70] years (Table 1).

Table 1: Distribution of patients according to age and gender
Age group (years)
18-30
31-50
51-70
Above 70
Total

Gender
Female

Male
No.
8
146
344
105
603

(%)
1.3
24.2
57.1
17.4
100

Out of the recruited 1203 patients who reported
for cataract surgery, 130 (10.8%) turned out to be
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No.
9
148
352
91
600

Total
(%)
1.5
24.7
58.7
15.1
100

No.
17
294
696
196
1203

(%)
1.4
24.4
57.9
16.3
100

positive for HBV, HCV and HIV. The total
prevalence of HBV and HCV in preoperative
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cataract patients was found to be 81/1203 (6.7%)
and 49 / 1203 (4.1%) respectively. Only one
female patient was found with a co-infection
with both HBsAg and Anti-HCV positive in
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parallel. Likewise, one male patient was HIV
positive. The most affected age group by HBV
infection was the age group (51-70) years with
(60.5%) (Table 2).

Table 2: Relationship between age groups and Hepatitis B Virus (HBV)

Age group (years)
18-30
31-50
51-70
Above 70
Total

HBV
reactive

Non-reactive
No.
(%)
16
1.4
275
24.5
647
57.7
184
16.4
1122
100

No.
1
19
49
12
81

Total
(%)
1.2
23.5
60.5
14.8
100

No.
17
294
696
196
1203

(%)
1.4
24.4
57.9
16.3
100

Pearson Correlation is not significant P value of (0.985) and (r= - 0.001).

The frequency of hepatitis B among age groups
(18– 30), (31 – 50), (51 – 70), and > 70 years
was 1.2% (1/81), 23.5% (19/81), 60.5% (49/81)
and 14.8% (12/81), respectively.
Meanwhile, the most affected age group by HCV
infection was those aged (51-70) years (53.0%)

(Table 3). Moreover, the frequency of hepatitis
C among the age groups (18– 30), (31 – 50), (51
– 70), and > 70 years was 0% (0/49), 22.5%
(11/49), 53.0% (26/49) and 24.5% (12/49),
respectively.

Table 3: Relationship between age groups and Hepatitis C Virus (HCV)

Age group (years)
18-30
31-50
51-70
Above 70
Total

HCV
reactive
Count
(%)
0
0.0
11
22.5
26
53.0
12
24.5
49
100

Non reactive
Count
(%)
17
1.5
283
24.5
670
58.1
184
15.9
1154
100

Total
Count
17
294
696
196
1203

(%)
1.4
24.4
57.9
16.3
100

Pearson Correlation is not significant P value of (0.167) and (r= 0.040).

Additionally, the prevalence of HBV was more
common in males 56.8% (46/81) than females
43.2% (35/81) (Table 4). On the other hand, the

prevalence of HCV was more common in
females with 55.1% (27/49) compared to males
44.9% (22/49) (Table 5).

Table 4: Relationship between Gender and Hepatitis B Virus (HBV)
Gender

Male
Female
Total

Non reactive
Count
(%)
557
49.6
565
50.4
1122
100

HBV
Reactive
Count
46
35
81

(%)
56.8
43.2
100

Total
Count
603
600
1203

(%)
51.1
49.9
100

Pearson Correlation is not significant P value of (0.214) and (r= - 0.036).
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Table 5: Relationship between Gender and Hepatitis C Virus (HCV)
Gender

Male
Female
Total

Non reactive
Count
(%)
581
50.3
573
49.7
1154
100

HCV
Reactive
Count
22
27
49

(%)
44.9
55.1
100

Total
Count
603
600
1203

(%)
51.1
49.9
100

Pearson Correlation is not significant P value of (0.455) and (r= 0.022).

Discussion:
Hepatitis B virus (HBV), Hepatitis C virus
(HCV) and Human Immunodeficiency virus
(HIV) are global diseases that are endemic in
many of the developing countries. The global
burden shows around 2 billion infections with
350 million chronic HBV cases worldwide, and
as anticipated, Yemen is also facing a huge
burden of these diseases. Although Yemen is in
a moderate HBV and HCV prevalence level,
chronic HBV is still a severe public health
problem with a carrier rate of 8 – 12% and HCV
of about 1.7 – 2.7% ]6, 11[.
All of the HBV, HCV and HIV are quickly
spreading in the majority of the developing
world. Most of the patients suffering from HBV
and HCV do not realize that they have got such
deadly viruses in their body and can transmit it to
non-infected healthy individuals.
A large
number of cases become positive for HBV, HCV
and HIV but they remain asymptomatic. They
are known as silent carriers ]17[ and may act as a
source of transmission of the virus.
There is increasing evidence that the prevalence
of HBsAg and anti-HCV in hospitalized surgical
patients is relatively high ]7[. The commonly
detected risk factors for such viruses infection
include; old age (above 50), gender (female), bad
hygiene, less awareness, some specific
occupations
and
exposure
to
surgical
interventions or unclean barbers ]8[. However,
the re-use of contaminated syringes, surgical
instruments and improperly screened blood
products are of the quite crucial risk factors. [13]
There is a lack of routine serological screening
prior to surgery which is one of the leading
factors for increased disease transmission.
Therefore, doctors and paramedical staff
involved in surgical practice are the at high risk
group of acquiring blood borne diseases from
patients on whom they operate ]3, 19[.
Nevertheless, such dilemma of viral hepatitis
magnitude in hospitalized patients is not
effectively controlled even though the
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asymptomatic patients who pose a huge risk of
spreading the infection to other patients and the
associated medical workers.
The World Health Organization considers HBV
and HCV as epidemic diseases mainly because
patients living with HBV and HCV can remain in
the subclinical stage, i.e.: positively infected
while undetected due to the asymptomatic nature
of the disease for decades before being
diagnosed. The prevalence of both HBV and
HCV in our population is alarming, not only for
the general population but also for the associated
general health care personnel ]3,19[.The
literature shows that the prevalence is continuing
to rise especially in certain regions such as some
rural areas of developing countries where the
percentage of infected individuals is significantly
higher than those reported ]10[.
In our series, out of 1,203 cataract patients
booked for surgery, 10.8% were positive for
HBV, HCV and HIV. Thus, the total prevalence
of HBV and HCV among them is 6.7% 4.1%,
respectively. Besides, the prevalence of HBV
infection is higher than that of the HCV in this
study, which goes with the findings of India and
contradicts with the findings of Pakistani
group]15[.
In our study, the higher frequency of HBV and
HCV were in the age group of (51 – 70) years
which
is
quite
equivalent
to
other
studies ]12[.This could be due to conducting the
study among cataract patients, where the
majority of whom is already of old age.
Moreover, among 81 affected patients with HBV
males 56.8% (46/81) were more common than
females 43.2% (35/81) and among 49 affected
patients with HCV females with 55.1% (27/49)
were more common in comparison to males
44.9% (22/49). The greater frequency of HBV
infection in males as compared to females could
be due to more social mobility in males than
females and thus greater vulnerability to be
infected especially in rural areas as compared to
females. This finding is comparable to the
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findings of a similar study done in Pakistan ]2[.
Unfortunately, once infected, these infections
show poor response to the available treatment
modalities. Therefore, precautionary methods
are considered as the best way to avoid the
spreading of this disease. Unlike HCV, several
vaccines have been developed for HBV that
provide
long
lasting
immunity
to
individuals ]21[. It is the most important
precautionary measure of HBV as a vaccinated
individual may never contract the infection ]13[.
Recently, the prevalence of HBV has
considerably declined in many countries since
the introduction of these immunizations. A
recent study in Yemen revealed that a high
response rate to HBV vaccine is being
recognized. However, a considerable proportion
(32.4%) of vaccinated children remains to be
reconsidered for either revaccination or booster
doses due to the lack and inadequate or low
response. The trend of decreasing antibody level
with increasing age suggests a need of careful
monitoring of HBV vaccine efficacy in Yemen
and similar countries ]18[.
All infections can be further avoided by the use
of disposable syringes, screened blood
transfusion, avoidance of sexual abuse, antiseptic
shaving and use of proper antiseptic measures in
hospitals, clinics and operating theaters ]4, 8[.
Public awareness regarding hazards and common
modes of disease transmission should be
transmitted through print and electronic media
and public awareness programs. Steps need to
be taken to abort this preventable disease.
There were however a number of limitations in
our study. This study was conducted among
patients of certain eye disease (cataract surgery
eligible patients) therefore; the prevalence we
assessed could be over or underestimated.
Another limitation of this study is due to the
study design, where other risk factors such as
previous surgeries, drug use and risky sexual
behavior which may influence the incidence of
hepatitis and HIV infections were not obtained.
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Further studies are needed to address these
issues.
With such higher prevalence of these viral
diseases in our population, it is important that
patients should be regularly screened for
Hepatitis B, Hepatitis C and HIV. Media should
be used as a tool to raise awareness in the public.
Conclusions:
Our findings in elective cataract surgery are very
alarming. Routine screening of patients booked
for surgery should be nationally applied
All patients undergoing an ophthalmic procedure
should be checked for anti HCV and HBsAg and
HIV. A solid policy outlining the preventive
practices is needed to stop this high burden of
hepatitis turning into public health disaster.
There is a need for implementing a screening of
Hepatitis B, Hepatitis C and HIV programs
among preoperative patients. Public awareness
regarding hazards and common modes of disease
transmission should be raised through electronic
media and nationally adopted public awareness
programs.
All patients undergoing an ophthalmic procedure
should be checked for anti HCV and HBsAg and
HIV. A solid policy outlining the preventive
practices is needed to stop this high burden of
hepatitis turning into public health disaster.
There is a need for implementing a screening of
Hepatitis B, Hepatitis C and HIV programs
among preoperative patients. Public awareness
regarding hazards and common modes of disease
transmission should be raised through electronic
media and nationally adopted public awareness
programs.
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مجمة جامعة حضرموت لمعموم الطبيعية والتطبيقية المجمد ,61العدد  ,6يونيو 9162م

تىاتر االلتهاب الكبدي ب  ،التهاب الكبد الىبائً س وفريوس نقص
املناعة البشرٌة يف املرضى الذٌن خيضعىن جلراحة الساد
أحمد موسى عبدالرحيم

محفوظ عبداهلل بامشموس
الممخص

الهدف من هذه الدراسة هو تقويم حاالت التهاب فيروس ب وفيروس ج وفيروس األيدز في المرضى الذين يخضعون لجراحة الساد (الماء
األبيض).أجريت هذه الدراسة من بين  6911مرضى فوق سن  61سنة الذين كان من المقرر إجراء جراحة إزالة المياه البيضاء في مستشفى
مغربي لمعيون في اليمن في الفترة من  6يناير إلى  16ديسمبر 9169م .أجري لممرضى فحوصات مخبرية لفيروس ب وفيروس ج وفيروس
األيدز وتم بعدها تحميل النتائج .إجمالي عدد المرضى الذين تم فحصهم كان  6911مرضى منهم  )%16.6( 111ذكور و %92.2( 111
إناث .متوسط العمر كان  69.12 + 12.21سنة .من أصل  6911حالة مياه بيضاء حجزت لمعممية الجراحية )%61.1( 611 ,حالة تبين
أنها موجبة لفيروس الكبد ب وفيروس الكبد ج وفيروس األيدز .معدل االنتشار الكمي لفيروس الكبد ب كان  16من  6911حاالت ()%1.1
وفيروس الكبد ج  92من  6911حاالت ( .)%9.6تم العثور عمى مريض واحد مصاب بعدوى مشتركة من فيروس الكبد (ب و ج) .بينما
مريض واحد ( )%1.11كان موجباً لفيروس األيدز  .نستنتج أن ارتفاع معدل االنتشار بنسبة  %61.1إللتهاب فيروس الكبد ب وفيروس الكبد
ج بين مرضى جراحات المياه البيضاء (الساد) لذلك نقترح أن الفحص الفيروسي قبل العممية لجميع المرضى يجب أن يكون إلزاميا كشرط

أساسي إل جراء الجراحة .كما يجب اتخاذ سياسة صمبة لتحديد الممارسات الوقائية كحاجة ماسة لمسيطرة عمى هذه الظاهرة ومنع عواقبها
السمبية.
كممات مفتاحية 3التهاب الكبد  , Bالتهاب الكبد  , Cفيروس نقص المناعة البشرية  ,جراحة الساد  ,الفحص
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